• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Body surface area-based dosing of 5-fluoruracil results in extensive interindividual variability in 5-fluorouracil exposure in colorectal cancer patients on FOLFOX regimens.

作者信息

Saam Jennifer, Critchfield Gregory C, Hamilton Stephanie A, Roa Benjamin B, Wenstrup Richard J, Kaldate Rajesh R

机构信息

Myriad Genetic Laboratories, Inc, Salt Lake City, UT, USA.

出版信息

Clin Colorectal Cancer. 2011 Sep;10(3):203-6. doi: 10.1016/j.clcc.2011.03.015. Epub 2011 Apr 28.

DOI:10.1016/j.clcc.2011.03.015
PMID:21855044
Abstract
摘要

相似文献

1
Body surface area-based dosing of 5-fluoruracil results in extensive interindividual variability in 5-fluorouracil exposure in colorectal cancer patients on FOLFOX regimens.基于体表面积的5-氟尿嘧啶给药导致接受FOLFOX方案治疗的结直肠癌患者中5-氟尿嘧啶暴露存在广泛的个体间差异。
Clin Colorectal Cancer. 2011 Sep;10(3):203-6. doi: 10.1016/j.clcc.2011.03.015. Epub 2011 Apr 28.
2
Response to chemotherapy in metastatic colorectal cancer after exposure to oxaliplatin in the adjuvant setting.辅助治疗中使用奥沙利铂后转移性结直肠癌患者的化疗反应。
Anticancer Res. 2013 Apr;33(4):1765-8.
3
Axitinib or bevacizumab plus FOLFIRI or modified FOLFOX-6 after failure of first-line therapy for metastatic colorectal cancer: a randomized phase II study.一线治疗转移性结直肠癌失败后，阿昔替尼或贝伐珠单抗联合 FOLFIRI 或改良 FOLFOX-6 方案：一项随机 II 期研究。
Clin Colorectal Cancer. 2013 Dec;12(4):239-47. doi: 10.1016/j.clcc.2013.09.001.
4
[Advances in the treatment of metastatic colorectal cancer with bevacizumab].[贝伐单抗治疗转移性结直肠癌的进展]
Tumori. 2006 Sep-Oct;92(5):suppl 1-12.
5
Always look at the bright side of drugs?
Acta Oncol. 2015 Feb;54(2):145-7. doi: 10.3109/0284186X.2014.1001874.
6
Pathologic complete response to neoadjuvant FOLFOX in combination with bevacizumab in unresectable metastatic colorectal carcinoma.新辅助FOLFOX联合贝伐单抗治疗不可切除转移性结直肠癌的病理完全缓解
Clin Colorectal Cancer. 2008 Mar;7(2):140-3. doi: 10.3816/CCC.2008.n.019.
7
First description of an uterine perforation potentially imputable to treatment with bevacizumab.首次描述了可能归因于贝伐单抗治疗的子宫穿孔。
Acta Oncol. 2012 Nov;51(8):1102-4. doi: 10.3109/0284186X.2012.689855. Epub 2012 Oct 1.
8
[The development of the first line treatment of metastatic colorectal cancer (mCRC)].[转移性结直肠癌（mCRC）一线治疗的发展]
Magy Onkol. 2009 Sep;53(3):237-46. doi: 10.1556/MOnkol.53.2009.3.1.
9
[Progress of chemotherapy in colorectal cancer].
Gan To Kagaku Ryoho. 2007 Nov;34(11):1771-6.
10
Selecting regimens in advanced colon cancer.晚期结肠癌治疗方案的选择
J Natl Compr Canc Netw. 2004 Sep;2 Suppl 3:S-19-24.

引用本文的文献

1
Pharmacogenomic-guided dosing of fluoropyrimidines beyond : time for a polygenic algorithm?氟嘧啶基于药物基因组学的给药之外：是时候采用多基因算法了吗？
Front Pharmacol. 2023 May 15;14:1184523. doi: 10.3389/fphar.2023.1184523. eCollection 2023.
2
The effect and therapeutic compliance of adjuvant therapy in patients with cholangiocarcinoma after R0 resection: a retrospective study.胆管癌患者R0切除术后辅助治疗的疗效及治疗依从性：一项回顾性研究
J Yeungnam Med Sci. 2023 Jan;40(1):65-77. doi: 10.12701/jyms.2022.00213. Epub 2022 May 26.
3
Micronutrient Food Supplements in Patients with Gastro-Intestinal and Hepatic Cancers.
胃肠道和肝癌症患者的微量营养素食物补充剂。
Int J Mol Sci. 2021 Jul 27;22(15):8014. doi: 10.3390/ijms22158014.
4
Clinical Benefit of Therapeutic Drug Monitoring in Colorectal Cancer Patients Who Received Fluorouracil-Based Chemotherapy.氟尿嘧啶为基础化疗的结直肠癌患者治疗药物监测的临床获益。
Med Sci Monit. 2021 Jul 31;27:e929474. doi: 10.12659/MSM.929474.
5
Association of 5-FU Therapeutic Drug Monitoring to DPD Phenotype Assessment May Reduce 5-FU Under-Exposure.5-氟尿嘧啶治疗药物监测与二氢嘧啶脱氢酶（DPD）表型评估相结合可能会减少5-氟尿嘧啶暴露不足的情况。
Pharmaceuticals (Basel). 2020 Nov 23;13(11):416. doi: 10.3390/ph13110416.
6
Evaluation of the 5-fluorouracil plasma level in patients with colorectal cancer undergoing continuous infusion chemotherapy.接受持续静脉滴注化疗的结直肠癌患者5-氟尿嘧啶血浆水平的评估。
Mol Clin Oncol. 2019 Sep;11(3):289-295. doi: 10.3892/mco.2019.1893. Epub 2019 Jul 3.
7
Therapeutic Drug Monitoring in Oncology: International Association of Therapeutic Drug Monitoring and Clinical Toxicology Recommendations for 5-Fluorouracil Therapy.肿瘤治疗药物监测：国际治疗药物监测和临床毒理学协会关于氟尿嘧啶治疗的建议。
Clin Pharmacol Ther. 2019 Mar;105(3):598-613. doi: 10.1002/cpt.1124. Epub 2018 Sep 11.
8
5-FU therapeutic drug monitoring as a valuable option to reduce toxicity in patients with gastrointestinal cancer.5-氟尿嘧啶治疗药物监测作为降低胃肠道癌患者毒性的一种有价值的选择。
Oncotarget. 2018 Jan 30;9(14):11559-11571. doi: 10.18632/oncotarget.24338. eCollection 2018 Feb 20.
9
Is monitoring of plasma 5-fluorouracil levels in metastatic / advanced colorectal cancer clinically effective? A systematic review.监测转移性/晚期结直肠癌患者血浆5-氟尿嘧啶水平在临床上是否有效？一项系统评价。
BMC Cancer. 2016 Jul 25;16:523. doi: 10.1186/s12885-016-2581-x.
10
Therapeutic drug monitoring of 5-fluorouracil.5-氟尿嘧啶的治疗药物监测
Cancer Chemother Pharmacol. 2016 Sep;78(3):447-64. doi: 10.1007/s00280-016-3054-2. Epub 2016 May 23.